PRIMEVAX IMMUNO-ONCOLOGY
PrimeVax Immuno-Oncology is developing a multi-mechanism treatment for cancer leveraging whole body systemic fever along with personalized neo-antigens. Our therapeutic design is to be the only one-time one-week cancer treatment. They combine dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting. We focus on cancer cells resistant to prior treatments.
PRIMEVAX IMMUNO-ONCOLOGY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Orange, California, United States
Country:
United States
Website Url:
http://www.primevax.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content Google Cloud
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.primevax.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
